Hundreds of doctors sent warnings for prescribing semaglutide on PBS to patients without diabetes
The Department of Health and Aged Care has identified the top 10% of doctors writing PBS scripts for patients without a history of type 2 diabetes.
Health officials have started a mass letter mail-out to doctors they suspect are using the PBS to prescribe subsidised semaglutide to patients without diabetes.
Without subsidies, Ozempic — the only PBS-subsidised brand of semaglutide — costs $150 for a prefilled pen.
